The use of BNP/NT-proBNP levels to guide HF therapy has also been studied extensively in the last decade. A series of studies have tested whether using plasma BNP or NT-proBNP as a target to guide ...

October 26, 2009 (Seattle, Washington) — An analysis from a large community-based study of older adults suggests that N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a "remarkable predictor" ...

Measuring N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels preoperatively among patients scheduled to undergo inpatient noncardiac surgery can strongly predict the risk of major cardiac ...

To explore the association of urinary N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations and closure of patent ductus arteriosus (PDA) in preterm infants. A prospective longitudinal ...

At this year's congress of the American Heart Association (AHA) in Chicago, November 13-17, new data on the use of NT-proBNP to guide heart failure therapy was presented by study investigators from ...

The implementation of a hormone-guided treatment strategy guided by N-terminal pro-B-type natriuretic peptide levels selectively improved longer-term mortality in patients 75 years and older with ...

Please provide your email address to receive an email when new articles are posted on . Baseline N-terminal pro-B natriuretic peptide in patients with HF with preserved ejection fraction accurately ...

In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...

Patients with heart failure (HF) with preserved ejection fraction (HFpEF) who presented for this study analysis with normal levels of N-terminal prohormone B-type natriuretic peptide (NT-proBNP) and ...

In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...

Blood pressure cuff Elevated NT-proBNP may represent a useful biomarker for the identification of individuals at high risk for CVD and mortality across the spectrum of blood and pulse pressures.